EMA committee recommends approval of an expanded indication for Merck’s Winrevair in adults with pulmonary arterial hypertension: Rahway, New Jersey Monday, December 15, 2025, 1 ...
The European Medicines Agency’s, EMA, committee recommended a change to extend the use of Eli Lilly’s (LLY) Mounjaro for the treatment of type 2 ...
ImmunityBio jumped by 7.76 percent on Friday to close at $2.36 apiece after securing the green light of the European ...
The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...
EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...
EMA recommends conditional authorization for ImmunityBio's Anktiva with BCG after a 71% complete response rate in ...
The European ​Medicines ‌Agency's committee on ‌Friday recommended a change to ⁠extend ‌the use of ‍Eli Lilly's blockbuster ...
Novo Nordisk A/S said its high-dose version of blockbuster Wegovy has been cleared by the European Union’s drug advisory board, opening the way for use of a shot that delivers more weight loss than ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
Dec 12 (Reuters) - The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...